Status | Study |
Completed |
Study Name: Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma Condition: Adult Alveolar Soft Part Sarcoma Adult Angiosarcoma Adult Date: 2010-06-29 Interventions: Drug: Gamma-Secretase Inhibitor RO4929097 |
Completed |
Study Name: Biomarkers in Tissue Samples From Patients With High-Risk Wilms Tumor Condition: Clear Cell Sarcoma of the Kidney Recurrent Wilms Tumor and Othe Date: 2010-05-05 Interventions: Genetic: DNA methylation analysis |
Completed |
Study Name: Dalteparin and Sunitinib Malate as First-Line Therapy in Treating Patients With Kidney Cancer That is Metastatic or Cannot Be Removed by Surgery Condition: Clear Cell Sarcoma of the Kidney Recurrent Renal Cell Carcinoma Date: 2010-02-01 Interventions: Drug: Dalteparin Given SC |
Recruiting |
Study Name: Study of Kidney Tumors in Younger Patients Condition: Clear Cell Sarcoma of the Kidney Congenital Mesoblastic Nephrom Date: 2009-05-09 Interventions: Other: laboratory biomarker analysis |
Completed |
Study Name: Phase 2 Study in Patients With MiT Tumors Condition: Renal Cell Carcinoma (RCC) Alveolar Soft Part Sarcoma (ASPS) Date: 2007-11-12 Interventions: Drug: ARQ 197 360 mg administered twice daily until disease progression or other discontinuation criteri |
Completed |
Study Name: Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors Condition: Childhood Renal Cell Carcinoma Clear Cell Renal Cell Carcinoma Date: 2006-06-08 Interventions: Drug: Doxorubicin Hydrochloride |
Active, not recruiting |
Study Name: Vaccine Trial for Clear Cell Sarcoma, Pediatric Renal Cell Carcinoma, Alveolar Soft Part Sarcoma and Children With Stage IV Melanoma Condition: Sarcoma, Clear Cell Sarcoma, Alveolar Soft Part Date: 2005-11-23 Interventions: Biological: GVAX 4 vaccines every two weeks |
Not yet recruiting |
Study Name: Chemotherapy Followed by Surgery and Radiation Therapy With or Without Stem Cell Transplant in Treating Patients With Relapsed or Refractory Wilms' Tumor or Clear Cell Sarcoma of the Kidney Condition: Kidney Cancer Date: 2001-10-11 Interventions: Biological: dactinomycin Drug: carboplatin |
Completed |
Study Name: Chemotherapy With or Without Surgery, Radiation Therapy, or Stem Cell Transplantation in Treating Young Patients With Kidney Tumors Condition: Kidney Cancer Date: 1999-11-01 Interventions: Biological: dactinomycin Other |
Completed |
Study Name: Combination Chemotherapy Alone or With Radiation Therapy in Treating Children With Kidney Cancer Condition: Kidney Cancer Date: 1999-11-01 Interventions: Biological: dactinomycin Biological: filgr |